ASH2L could activate the transcription of HIPK2 (a key regulator of renal fibrosis) and increase its protein expression through H3K4me3 in the HIPK2 promoter region, thereby mediating renal fibrosis and inflammation in DN. Here, ASH2L is linked to liver dysplastic nodule.